Aim: To evaluate the effectiveness of a mobile diabetic retinopathy (DR) screening campaign with a non-mydriatic camera to encourage diabetics to undergo a subsequent ophthalmic follow-up. Methods: Diabetic patients who underwent free DR screening with a non-mydriatic fundus camera were given the recommendation to have an ophthalmic visit, in a time frame suited to the DR stage or in case abnormalities in the macula, the optic nerve or intra-ocular pressure were detected. The photographs were performed by a trained orthoptist. The date of the visit to their ophthalmologist and the report of this consultation were recorded. Results: During 5 annual campaigns, 4,699 diabetics were screened. Of the 1,573 ophthalmic examinations recommended at the screening, 1,241 (79%) were actually conducted. A total of 623 new cases of DR were found in the course of this screening campaign, with a fair concordance between the diagnosis suggested at screening and the examination by the ophthalmologist (κ = 0.48). Conclusion: Information and recommendations given during DR screening helped to reintroduce patients to a regular ophthalmic follow-up, at least in the short term.

Keywords:
Diabetic retinopathy, Mobile screening, Ophthalmic follow-up, Digital fundus photography
1.
Frank RN: Diabetic retinopathy. N Engl J Med 2004;350:48-58.
2.
Ferris FL 3rd: How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1291.
3.
Haute Autorité de Santé: Dépistage de la rétinopathie diabétique par lecture différée de photographies du fond d'oeil. Saint-Denis La Plaine, 2010.
4.
Observatoire Régional de la Santé de Bourgogne: Tableau de bord sur les maladies chroniques en Bourgogne. Chapitre 3: diabète. Dijon, 2007.
5.
Kusnik-Joinville O, Weill A, et al: Diabète traité en France en 2007: un taux de prévalence proche de 4% et des disparités géographiques croissantes. Bull Epidémiol Hebd 2008;43:409-413.
6.
Deb-Joardar N, Germain N, Thuret G, Manoli P, Garcin AF, Millot L, Gavet Y, Estour B, Gain P: Screening for diabetic retinopathy by ophthalmologists and endocrinologists with pupillary dilation and a nonmydriatic digital camera. Am J Ophthalmol 2005;140:814-821.
7.
Screening for diabetic retinopathy in Europe 15 years after the St. Vincent declaration. The Liverpool declaration 2005. www.drscreening2005.org.uk.
8.
Massin PM-MC, David D, Lee-Robin SH: Evaluation HAS - interprétation des photographies du fond d'oeil, suite à une rétinographie avec ou sans mydriase. Evaluation HAS 2007. http://www.has-sante.fr/portail/upload/docs/application/pdf/synthese_retinographie.pdf.
9.
Ahmed J, Ward TP, Bursell SE, Aiello LM, Cavallerano JD, Vigersky RA: The sensitivity and specificity of nonmydriatic digital stereoscopic retinal imaging in detecting diabetic retinopathy. Diabetes Care 2006;29:2205-2209.
10.
Aptel F, Denis P, Rouberol F, Thivolet C: Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography. Diabetes Metab 2008;34:290-293.
11.
Massin P, Erginay A, Ben Mehidi A, Vicaut E, Quentel G, Victor Z, Marre M, Guillausseau PJ, Gaudric A: Evaluation of a new non-mydriatic digital camera for detection of diabetic retinopathy. Diabet Med 2003;20:635-641.
12.
Massin P, Aubert JP, Erginay A, Bourovitch JC, Benmehidi A, Audran G, Bernit B, Jamet M, Collet C, Laloi-Michelin M, Guillausseau PJ, Gaudric A, Marre M: Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. Diabetes Metab 2004;30:451-457.
13.
Beynat J, Charles A, Astruc K, Metral P, Chirpaz L, Bron AM, Creuzot-Garcher C: Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. Diabetes Metab 2009;35:49-56.
14.
Leese GP, Ahmed S, Newton RW, Jung RT, Ellingford A, Baines P, Roxburgh S, Coleiro J: Use of mobile screening unit for diabetic retinopathy in rural and urban areas. Br Med J 1993;306:187-189.
15.
Lecleire-Collet A, Erginay A, Angioi-Duprez K, Deb-Joardar N, Gain P, Massin P: A new grading system from color fundus photographs for screening for diabetic retinopathy (in French). J Fr Ophtalmol 2007;30:674-687.
16.
Xu L, Jonas JB, Cui TT, You QS, Wang YX, Yang H, Li JJ, Wei WB, Liang QF, Wang S, Yang XH, Zhang L: Beijing eye public health care project. Ophthalmology 2012;119:1167-1174.
17.
You QS, Xu L, Wang YX, Liang QF, Cui TT, Yang XH, Yang H, Jonas JB: Prevalence of diabetic retinopathy as cause for visual impairment: the Beijing public health care project. Clin Experiment Ophthalmol 2013;41:608-609.
18.
Delcourt C, Massin P, Rosilio M: Epidemiology of diabetic retinopathy: expected vs. reported prevalence of cases in the French population. Diabetes Metab 2009;35:431-438.
19.
Legorreta AP, Hasan MM, Peters AL, Pelletier KR, Leung KM: An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. A bicoastal experience. Diabetes Care 1997;20:520-523.
20.
Mukamel DB, Bresnick GH, Wang Q, Dickey CF: Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 1999;6:61-72.
21.
Schoenfeld ER, Greene JM, Wu SY, Leske MC: Patterns of adherence to diabetes vision care guidelines: baseline findings from the diabetic retinopathy awareness program. Ophthalmology 2001;108:563-571.
22.
Moss SE, Klein R, Klein BE: Factors associated with having eye examinations in persons with diabetes. Arch Fam Med 1995;4:529-534.
23.
Berland Y: Commission de la démographie médicale, 2005. http://www.sante.gouv.fr/IMG/pdf/rapport_berland.pdf.
24.
Bonaldi C, Romon I, Fagot-Campagna A: Impacts du vieillissement de la population et de l'obésité sur l'évolution de la prévalence du diabète traité: situation de la France métropolitaine à l'horizon 2016. Bull Epidémiol Hebd 2006;10:69-71.
25.
Bour T, Corre C: L'ophtalmologie et la filière visuelle en France. Strasbourg, Syndicat National des Ophtalmologistes de France, 2006.
26.
Soulie-Strougar M, Charles A, Metral P, Quercia P, Souchier M, Chirpaz L, Bron A, Creuzot-Garcher C: Screening diabetic retinopathy in Burgundy with an itinerant nonmydriatic camera (in French). J Fr Ophtalmol 2007;30:121-126.
27.
Taylor CR, Merin LM, Salunga AM, Hepworth JT, Crutcher TD, O'Day DM, Pilon BA: Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology: The Vine Hill study. Diabetes Care 2007;30:574-578.
28.
Fosse S, Romon I, Druet C, Fagot-Campagna A: Echantillon national témoin représentatif des personnes diabétiques (Entred). Saint-Maurice, Institut de veille sanitaire, 2012.
29.
Jones S, Edwards RT: Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010;27:249-256.
30.
Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI: Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714-1718.
31.
Will JC, German RR, Schuman E, Michael S, Kurth DM, Deeb L: Patient adherence to guidelines for diabetes eye care: results from the Diabetic Eye Disease Follow-Up Study. Am J Public Health 1994;84:1669-1671.
32.
Chow SP, Aiello LM, Cavallerano JD, Katalinic P, Hock K, Tolson A, Kirby R, Bursell SE, Aiello LP: Comparison of nonmydriatic digital retinal imaging versus dilated ophthalmic examination for nondiabetic eye disease in persons with diabetes. Ophthalmology 2006;113:833-840.
33.
Cavallerano JD, Aiello LP, Cavallerano AA, Katalinic P, Hock K, Kirby R, Aiello LM: Nonmydriatic digital imaging alternative for annual retinal examination in persons with previously documented no or mild diabetic retinopathy. Am J Ophthalmol 2005;140:667-673.
34.
Gomez-Ulla F, Fernandez MI, Gonzalez F, Rey P, Rodriguez M, Rodriguez-Cid MJ, Casanueva FF, Tome MA, Garcia-Tobio J, Gude F: Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. Diabetes Care 2002;25:1384-1389.
35.
Rani PK, Raman R, Sharma V, Mahuli SV, Tarigopala A, Sudhir RR, Kumaramanickavel G, Sharma T: Analysis of a comprehensive diabetic retinopathy screening model for rural and urban diabetics in developing countries. Br J Ophthalmol 2007;91:1425-1429.
36.
Creuzot-Garcher C, Malvitte L, Sicard AC, Guillaubey A, Charles A, Beiss JN, Bron A: How to improve screening for diabetic retinopathy: the Burgundy experience. Diabetes Metab 2010;36:114-119.
37.
Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Philip S, Black MW, Doig J, Lee N, Briggs A, Hothersall EJ, Morris AD, Lindsay RS, McKnight JA, Pearson DW, Sattar NA, Wild SH, McKeigue P, Colhoun HM: Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish diabetic retinopathy screening programme. Diabetologia 2013;56:1716-1725.
38.
Maamari RN, Keenan JD, Fletcher DA, Margolis TP: A mobile phone-based retinal camera for portable wide field imaging. Br J Ophthalmol 2014;98:438-441.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.